Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Rivastigmine exposure provided by a transdermal patch versus capsules.

Mercier, Francois and Lefevre, Gilbert and Huang, Hsun-Lun Aaron and Schmidli, Heinz and Amzal, Billy and Appel Dingemanse, Silke (2007) Rivastigmine exposure provided by a transdermal patch versus capsules. Current medical research and opinion, 23 (12). pp. 3199-3204. ISSN 1473-4877

Abstract

The rivastigmine transdermal patch is the first transdermal treatment for Alzheimer's disease (AD) and dementia associated with Parkinson's disease. The objective of this study was to evaluate the pharmacokinetics of rivastigmine following transdermal delivery by a patch versus oral delivery with conventional capsules in a population of AD patients.

Item Type: Article
Related URLs:
Related URLs:
Date Deposited: 28 Jan 2012 00:45
Last Modified: 01 Feb 2013 00:47
URI: https://oak.novartis.com/id/eprint/5149

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.